Literature DB >> 16134562

A two-stage sampling method for clinical surveillance of individuals in care for HIV infection in the United States.

Patrick S Sullivan1, John M Karon, Faye E Malitz, Stephanie Broyles, Eve D Mokotoff, Susan E Buskin, Patricia L Fleming.   

Abstract

OBJECTIVES: The goals of this study were two-fold: (1) to describe methods for drawing a population-based sample of individuals in care for HIV infection and (2) to compare data from the sample with data from existing surveillance systems that describe care for HIV.
METHODS: The authors implemented a two-stage sampling method, using local HIV/AIDS surveillance data as a sampling frame of HIV care providers in three states. At selected providers, medical records of a random sample of patients were abstracted.
RESULTS: The medical records of a number of patients, ranging from 253 to 374 individuals per state, were abstracted. The demographics of sampled individuals and of individuals reported to the local HIV/AIDS surveillance program were similar; however, differences existed in the proportion of individuals receiving HIV care consistent with treatment guidelines between the sample and a contemporary facility-based supplemental surveillance project. The median design effect for outcomes collected in the sample was 1.8 (range=0.5-29.6).
CONCLUSIONS: This survey method is feasible for collecting population-based data on patients in care for HIV. Sample size and some design elements should be changed in future studies to increase precision of estimates and usefulness of data for local planning and evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16134562      PMCID: PMC1497713          DOI: 10.1177/003335490512000304

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  13 in total

1.  HIV/AIDS surveillance in the United States, 1981-2001.

Authors:  Allyn K Nakashima; Patricia L Fleming
Journal:  J Acquir Immune Defic Syndr       Date:  2003-02       Impact factor: 3.731

2.  National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample.

Authors:  M R Frankel; M F Shapiro; N Duan; S C Morton; S H Berry; J A Brown; M A Burnam; S E Cohn; D P Goldman; D F McCaffrey; S M Smith; P A St Clair; J F Tebow; S A Bozzette
Journal:  Health Serv Res       Date:  1999-12       Impact factor: 3.402

3.  National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study.

Authors:  M F Shapiro; M L Berk; S H Berry; C A Emmons; L A Athey; D C Hsia; A A Leibowitz; C A Maida; M Marcus; J F Perlman; C L Schur; M A Schuster; J W Senterfitt; S A Bozzette
Journal:  Health Serv Res       Date:  1999-12       Impact factor: 3.402

4.  Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group.

Authors:  A D McNaghten; D L Hanson; J L Jones; M S Dworkin; J W Ward
Journal:  AIDS       Date:  1999-09-10       Impact factor: 4.177

5.  The completeness, validity, and timeliness of AIDS surveillance data.

Authors:  R M Klevens; P L Fleming; J Li; C G Gaines; K Gallagher; S Schwarcz; J M Karon; J W Ward
Journal:  Ann Epidemiol       Date:  2001-10       Impact factor: 3.797

6.  Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997.

Authors:  L M Lee; J M Karon; R Selik; J J Neal; P L Fleming
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

7.  Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds.

Authors:  M S Dworkin; D L Hanson; J E Kaplan; J L Jones; J W Ward
Journal:  J Infect Dis       Date:  2000-07-14       Impact factor: 5.226

8.  Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999.

Authors:  L C Hsu; E Vittinghoff; M H Katz; S K Schwarcz
Journal:  J Acquir Immune Defic Syndr       Date:  2001-12-01       Impact factor: 3.731

9.  Racial differences in the use of drug therapy for HIV disease in an urban community.

Authors:  R D Moore; D Stanton; R Gopalan; R E Chaisson
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

10.  Spectrum of disease in persons with human immunodeficiency virus infection in the United States.

Authors:  K M Farizo; J W Buehler; M E Chamberland; B M Whyte; E S Froelicher; S G Hopkins; C M Reed; E D Mokotoff; D L Cohn; S Troxler
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

View more
  6 in total

1.  HIV behavioral surveillance in the U.S.: a conceptual framework.

Authors:  Amy Lansky; Patrick S Sullivan; Kathleen M Gallagher; Patricia L Fleming
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  Progress toward implementation of integrated systems for surveillance of HIV infection and morbidity in the United States.

Authors:  Patrick S Sullivan; Matthew T McKenna; Robert S Janssen
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

3.  Quality of care for HIV infection provided by Ryan White Program-supported versus Non-Ryan White Program-supported facilities.

Authors:  Patrick S Sullivan; Maxine Denniston; Eve Mokotoff; Susan Buskin; Stephanie Broyles; A D McNaghten
Journal:  PLoS One       Date:  2008-09-22       Impact factor: 3.240

4.  Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach.

Authors:  A D McNaghten; Mitchell I Wolfe; Ida Onorato; Allyn K Nakashima; Ronald O Valdiserri; Eve Mokotoff; Raul A Romaguera; Alice Kroliczak; Robert S Janssen; Patrick S Sullivan
Journal:  PLoS One       Date:  2007-06-20       Impact factor: 3.240

5.  Use of a population-based survey to determine incidence of AIDS-defining opportunistic illnesses among HIV-positive persons receiving medical care in the United States.

Authors:  Patrick S Sullivan; Maxine Denniston; Ad McNaghten; Susan E Buskin; Stephanie T Broyles; Eve D Mokotoff
Journal:  AIDS Res Ther       Date:  2007-09-12       Impact factor: 2.250

6.  Structural and Behavioral Correlates of HIV Infection among Pregnant Women in a Country with a Highly Generalized HIV Epidemic: A Cross-Sectional Study with a Probability Sample of Antenatal Care Facilities in Swaziland.

Authors:  Bhekumusa Wellington Lukhele; Teeranee Techasrivichien; S Pilar Suguimoto; Patou Masika Musumari; Christina El-Saaidi; Samson Haumba; Oslinah Buru Tagutanazvo; Masako Ono-Kihara; Masahiro Kihara
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.